469 Cooperation between checkpoint inhibitors targeting the PD-1/PD-L1 axis and ATRC-101, a novel clinical-stage candidate for the treatment of solid tissue malignancies
Amy Manning-Bog, Jeff DeFalco, Alexander Scholz, Iraz Aydin, Nikhil Vad, Cathrin Czupalla, Felix Chu, Mauricio Velasco-Delgado, Michael Harbell, Judevin Lugar-Supagay, Yvonne Leung, Shaun Lippow, Anne Ye, Ish Dhawan, Gilson Baia, Dai-Chen Wu, Carl Millward, Mark Whidden, Jonathan Benjamin, John Vivian, Ngan Nguyen, William Robinson, Tito Serafini, Daniel Emerling, Norman Greenberg
Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A286-A287; DOI: 10.1136/jitc-2020-SITC2020.0469
